Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
Gapping stocks in Friday's session Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Friday's pre-market session: top gainers and losers Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing requirements.
Which Healthcare Stock Is the Best Buy Right Now? Healthcare stocks provide a combination of upstarts with a high risk, high reward proposition to established firms that can be a defensive maneuver.
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.
